These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer.
    Author: Huang RY, Chung VY, Thiery JP.
    Journal: Curr Drug Targets; 2012 Dec; 13(13):1649-53. PubMed ID: 23061545.
    Abstract:
    Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Discovery of novel therapeutic opportunities for EOC is important for the improvement of clinical outcome of the patients. Emerging evidence is suggesting that epithelial-mesenchymal transition (EMT) plays a crucial role in the aggressiveness in EOC including increasing migration and invasion ability, contributing to chemoresistance and cancer stem cell populations. Targeting EMT in EOC thus offers an attractive therapeutic option.
    [Abstract] [Full Text] [Related] [New Search]